Form 8-K Coherus BioSciences, For: Sep 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Coherus BioSciences (CHRS) Increases ATM Offering Program by $28.75M
September 12, 2023 6:14 AM EDTOn May 15, 2023, Coherus BioSciences (NASDAQ: CHRS) previously announced that it reduced the amount of shares that could be issued and sold pursuant to its at-the-market program (ATM) with Cowen and Company, LLC (TD Cowen) in an amount equal to $86.25 million. The reduction in the amount... More
